Solitary bone tumor imaging reporting and data system (BTI-RADS): initial assessment of a systematic imaging evaluation and comprehensive reporting method
- 25 March 2021
- journal article
- research article
- Published by Springer Nature in European Radiology
- Vol. 31 (10) , 7637-7652
Abstract
Objectives Identify the most pertinent imaging features for solitary bone tumor characterization using a multimodality approach and propose a systematic evaluation system. Methods Data from a prospective trial, including 230 participants with histologically confirmed bone tumors, typical “do not touch” lesions, and stable chondral lesions, were retrospectively evaluated. Clinical data, CT, and MR imaging features were analyzed by a musculoskeletal radiologist blinded to the diagnosis using a structured report. The benign-malignant distribution of lesions bearing each image feature evaluated was compared to the benign-malignant distribution in the study sample. Benign and malignant indicators were identified. Two additional readers with different expertise levels independently evaluated the study sample. Results The sample included 140 men and 90 women (mean age 40.7 ± 18.3 years). The global benign-malignant distribution was 67–33%. Seven imaging features reached the criteria for benign indicators with a mean frequency of benignancy of 94%. Six minor malignant indicators were identified with a mean frequency of malignancy of 60.5%. Finally, three major malignant indicators were identified (Lodwick-Madewell grade III, aggressive periosteal reaction, and suspected metastatic disease) with a mean frequency of malignancy of 82.4%. A bone tumor imaging reporting and data system (BTI-RADS) was proposed. The reproducibility of the BTI-RADS was considered fair (kappa = 0.67) with a mean frequency of malignancy in classes I, II, III, and IV of 0%, 2.2%, 20.1%, and 71%, respectively. Conclusion BTI-RADS is an evidence-based systematic approach to solitary bone tumor characterization with a fair reproducibility, allowing lesion stratification in classes of increasing malignancy frequency. Trial registration Clinical trial number NCT02895633. Key Points • The most pertinent CT and MRI criteria allowing bone tumor characterization were defined and presented. • Lodwick-Madewell grade III, aggressive periosteal reaction, and suspected metastatic disease should be considered major malignant indicators associated with a frequency of malignancy over 75%. • The proposed evidence-based multimodality reporting system stratifies solitary bone tumors in classes with increasing frequencies of malignancy.Keywords
This publication has 45 references indexed in Scilit:
- Radiography in the Initial Diagnosis of Primary Bone TumorsAmerican Journal of Roentgenology, 2013
- Early symptoms of bone and soft tissue sarcomas: could they be diagnosed earlier?The Annals of The Royal College of Surgeons of England, 2012
- Radiographic Analysis of Solitary Bone LesionsRadiologic Clinics of North America, 2011
- Imaging of Primary Malignant Bone Tumors (Nonhematological)Radiologic Clinics of North America, 2011
- When should we biopsy a solitary central cartilaginous tumor of long bones? Literature review and management proposalEuropean Journal of Radiology, 2011
- PET/CT Characterization of Fibroosseous Defects in Children:18F-FDG Uptake Can Mimic Metastatic DiseaseAmerican Journal of Roentgenology, 2006
- Usefulness of radiography in differentiating enchondroma from central grade 1 chondrosarcoma.American Journal of Roentgenology, 1997
- MR imaging of tumor and tumorlike lesions of bone and soft tissue.American Journal of Roentgenology, 1990
- Herniation pit of the femoral neckAmerican Journal of Roentgenology, 1982
- Bone Destruction not Demonstrable by RadiographyBritish Journal of Radiology, 1951